Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
Evaluation of Fiasp (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy

This is a pilot outpatient study conducted at Stanford to obtain preliminary data on how Fiasp works in a closed-loop system and to determine if any changes need to be made to the 670G pump to optimize the use of Fiasp.

hemoglobin a1c
insulin
fiasp
novolog
glycosylated hemoglobin
  • 126 views
  • 08 Nov, 2020
  • 1 location
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients

The aim of this study is to compare the pharmacokinetic (PK) profile of diluted insulin aspart (U25) with undiluted insulin aspart (U100) in school-aged children and adolescents with type 1

  • 0 views
  • 26 Jan, 2020
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes

insulins mimicking the physiological secretion more closely has led to ultra-fast insulins (fast aspart), allowing for postprandial hyperglycaemia to be better controlled. In Type 1 diabetics treated with

  • 0 views
  • 26 Aug, 2020
  • 1 location
Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

The purpose of the project is to shown whether a little dose of a short acting insulin analogue given 3 time daily before the meals compared with placebo could normalise the increase in blood glucose after teh meals in diet treated Type 2 diabetic patients.

fasting blood glucose
fasting
  • 1 views
  • 07 Nov, 2020
  • 1 location
D-aspartate and Therapeutic Exercise

An important mechanism responsible for clinical recovery after neurological damage of different types is synaptic plasticity. Nervous tissue can enhance or de-energize inter-neuronal transmission at synaptic level in a lasting way. By increasing the efficiency of synaptic transmission, through long-term potentiation (LTP), it is possible to compensate for the loss …

neurological injury
stroke
neurosurgery
  • 76 views
  • 08 Nov, 2020
  • 1 location
Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart

The main objective of the study is to determine whether automated closed-loop using faster-acting insulin aspart will improve glucose control and reduce the burden of hypoglycaemia over a 23

  • 0 views
  • 18 Jan, 2021
  • 1 location
The Efficacy and Safety of Faster Insulin Aspart (Fiasp ) Compared to Conventional Insulin Aspart (NovoLog ) as Correction Bolus

plateau point", primary endpoint) and return to premeal glucose target if feasible (secondary endpoint) between Fiasp and conventional insulin aspart when used as a correction bolus. These endpoints will

severe hypoglycaemia
hemoglobin a1c
insulin
fiasp
novolog
  • 35 views
  • 02 Dec, 2020
  • 1 location
Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

Fast-acting insulin aspart (faster aspart) will be tested to see how well it works and if it is safe. The study compares 2 medicines for type 1 and type 2 diabetes - faster aspart (a new

  • 0 views
  • 17 Jan, 2021
  • 23 locations
Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

recommended method to reduce exercise-associated hypoglycemic risk. The impact of faster acting Aspart (FiAsp) pharmacokinetic on hypoglycemic risk has not yet been explored. This study will explore two

hypoglycemic drugs
hemoglobin a1c
insulin
fiasp
hypoglycemia
  • 8 views
  • 17 Jun, 2020
  • 2 locations
Comparison of Pharmacokinetics Safety Tolerability and Pharmacodynamics of Biocon Insulin Tregopil and Insulin Aspart

Multi-centre, open label, multiple ascending dose trial in patients with type 1 diabetes mellitus

c-peptide
insulin
fasting
body mass index
diabetes
  • 1 views
  • 24 Sep, 2020
  • 2 locations